COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,196 Articles (22,204 medRxiv, 7,992 bioRxiv)

Most recent first Previous |  Page 284: Articles 2831-2840  | Next

Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor binding domain (RBD)
Kumru, O. S., Bajoria, S., Kaur, K., Hickey, J. M., Van Slyke, G., Doering, J., Berman, K., Richardson, C., Lien, H., Kleanthous, H., Mantis, N. J., Joshi, S. B., Volkin, D. B.
10.1101/2023.07.10.548406 — Posted: 2023-07-11
Studies on the selectivity of the SARS-CoV-2 papain-like protease reveal the importance of the P2' proline of the viral polyprotein
Chan, H. T. H., Brewitz, L., Strain-Damerell, C., Lukacik, P., Walsh, M. A., Schofield, C. J., Duarte, F.
10.1101/2023.07.11.548309 — Posted: 2023-07-11
Proteome profiling of nasopharynx reveals pathophysiological signature of COVID-19 disease severity
Ooi, A., Esau, L. E., Pugachev, A., Groen, A., Sara Mfarrej, R., Salunke, R. P., Subudhi, A. K., Ben-Rached, F., Alofi, F., Alsomali, A., Khogeer, A., Hashem, A. M., Almontashiri, N., Magistretti, P. J., Hala, S., Pain, A.
10.1101/2023.07.09.548285 — Posted: 2023-07-10
High-resolution map of the Fc-functions mediated by COVID-19 neutralizing antibodies
Paciello, I., Maccari, G., Pantano, E., Andreano, E., Rappuoli, R.
10.1101/2023.07.10.548360 — Posted: 2023-07-10
Antimicrobial peptides and other potential biomarkers of critical illness in Sars-CoV-2 patients with acute kidney injury
dos Santos, L. F. T., Barbeiro, H. V., Barbeiro, D. F., de Souza, H. P., Pinheiro Da Silva, F.
10.1101/2023.07.08.23292389 — Posted: 2023-07-09
Comparative Reconstruction of SARS-CoV-2 transmission in three African countries using a mathematical model integrating immunity data.
neffeti, b., kebir, a., ben aribi, w., Diarra, M., schoenhals, m., vigan-womas, i., dellagi, k., ben miled, s.
10.1101/2023.07.07.23292215 — Posted: 2023-07-08
Poor Hemorrhagic Stroke Outcomes During the COVID-19 Pandemic Are Driven by Socioeconomic Disparities
Bako, A. T., Potter, T. B. H., Pan, A. P., Borei, K. A., Prince, T., Britz, G., Vahidy, F. S.
10.1101/2023.07.07.23292399 — Posted: 2023-07-08
Association of Chronotype and Shiftwork with COVID-19 Infection
Quan, S., Weaver, M. D., Czeisler, M. E., Barger, L. K., Booker, L. A., Howard, M. E., Jackson, M. L., Lane, R. I., McDonald, C. F., Ridgers, A., Robbins, R., Verma, P., Rajaratnam, S. M., Czeisler, C. A.
10.1101/2023.07.06.23292337 — Posted: 2023-07-08
Human complement Factor H and Properdin act as soluble pattern recognition receptors and differentially modulate SARS-CoV-2 Infection
Beirag, N., Varghese, P. M., Kumar, C., Idicula-Thomas, S., Mayora Neto, M., Khan, H. A., Sim, R. B., Madan, T., Temperton, N. J., Kishore, U.
10.1101/2023.07.07.548083 — Posted: 2023-07-08
Long-term symptom profiles after COVID-19 vs other acute respiratory infections: a population-based observational study (COVIDENCE UK)
Vivaldi, G., Pfeffer, P. E., Talaei, M., Basera, J., Shaheen, S. O., Martineau, A. R.
10.1101/2023.07.06.23292296 — Posted: 2023-07-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).